Therapeutic time window important factor for cord blood cell transplantation after stoke
A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within ...
Oct 1, 2012
0
0